Metabolic reprogramming is now recognized as a hallmark of cancer, playing a pivotal role in tumor progression, therapeutic resistance, immune evasion, and ...

This infographic outlines the mechanisms at the heart of PD and highlights investigational therapies, from gene and cell-based approaches to innovations targeting α-synuclein and neuroinflammation.